Thyroid Foundation Of Canada |

Health Canada Approves Tepezza

Health Canada Approves Tepezza TEPEZZA from Amgen Canada “reduces eye bulging and double vision. It also improves the signs and symptoms of Thyroid Eye Disease (TED), including eye pain, redness, and swelling.” Approval by Health Canada is the first step in a...

Regulatory Review of New TED Drug

Regulatory Review of New TED Drug TFC is supporting the Canadian regulatory review of the teprotumumab (Tepezza) drug for treating Thyroid Eye Disease produced by Amgen biopharmaceuticals. This review is part of the standard Health Technology Assessment process...

Thyroid Cancer Survivors Survey

Thyroid Cancer Survivors Survey University of Calgary How are you doing? A team of clinical researchers and thyroid cancer survivors are looking into thyroid cancer patient experiences, treatment satisfaction, and opportunities to improve thyroid cancer care...

New RFA Facility in Halifax

New RFA Facility in Halifax A new Radio Frequency Ablation (RFA) facility for thyroid nodules is now available at the Bayers Lake Community Outpatient Centre, Halifax. Location: Nova Scotia Health AuthorityBayers Lake Community Outpatient Centre420 Susie Lake...

Thyroid Eye Disease Survey

Thyroid Eye Disease Survey The survey has now been completed. Thank you to all who participated. ...

Autoimmune Diseases Research

Autoimmune Diseases Research Survey The University of Cambridge, England, is conducting a research project on the impact of autoimmune diseases on health and quality of life, with a special emphasis on autoimmune diseases such as thyroid conditions....

« Older Entries

Next Entries »

Health Canada Approves Tepezza

Regulatory Review of New TED Drug

Thyroid Cancer Survivors Survey

New RFA Facility in Halifax

Thyroid Eye Disease Survey

Autoimmune Diseases Research

Help us to Help Others

Awareness/Education

Patient Support

Research

Quick Survey